LymphedemaV1, Main, Exploration, bibRecord, 00DE44

Indirect lymphography with iotrolan.

Identifieur interne : 00DE44 ( Main/Exploration ); précédent : 00DE43; suivant : 00DE45

Indirect lymphography with iotrolan.

Auteurs : H. Partsch ; C. Stöberl ; M. Wruhs ; B I Wenzel-Hora

Source :

Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband [ 0178-4609 ] ; 1989.

RBID : pubmed:2568790

Descripteurs français

KwdFr :
- Acides triiodo-benzoïques (administration et posologie), Essais cliniques comme sujet, Humains, Iodo-benzoates, Lymphoedème (imagerie diagnostique), Lymphographie, Méthode en double aveugle, Produits de contraste (administration et posologie), Relation dose-effet des médicaments.
MESH :
- administration et posologie : Acides triiodo-benzoïques, Produits de contraste.
- imagerie diagnostique : Lymphoedème.
- Essais cliniques comme sujet, Humains, Iodo-benzoates, Lymphographie, Méthode en double aveugle, Relation dose-effet des médicaments.

English descriptors

KwdEn :
- Clinical Trials as Topic, Contrast Media (administration & dosage), Dose-Response Relationship, Drug, Double-Blind Method, Humans, Iodobenzoates, Lymphedema (diagnostic imaging), Lymphography, Triiodobenzoic Acids (administration & dosage).
MESH :
- chemical , administration & dosage : Contrast Media, Triiodobenzoic Acids.
- diagnostic imaging : Lymphedema.
- Clinical Trials as Topic, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Iodobenzoates, Lymphography.

Abstract

Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.

PubMed: 2568790

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Indirect lymphography with iotrolan.</title>
<author><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name>
</author>
<author><name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name>
</author>
<author><name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name>
</author>
<author><name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2568790</idno>
<idno type="pmid">2568790</idno>
<idno type="wicri:Area/PubMed/Corpus">006083</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006083</idno>
<idno type="wicri:Area/PubMed/Curation">006083</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006083</idno>
<idno type="wicri:Area/PubMed/Checkpoint">006083</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006083</idno>
<idno type="wicri:Area/Ncbi/Merge">007042</idno>
<idno type="wicri:Area/Ncbi/Curation">007042</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007042</idno>
<idno type="wicri:doubleKey">0178-4609:1989:Partsch H:indirect:lymphography:with</idno>
<idno type="wicri:Area/Main/Merge">00EA80</idno>
<idno type="wicri:Area/Main/Curation">00DE44</idno>
<idno type="wicri:Area/Main/Exploration">00DE44</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Indirect lymphography with iotrolan.</title>
<author><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name>
</author>
<author><name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name>
</author>
<author><name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name>
</author>
<author><name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name>
</author>
</analytic>
<series><title level="j">Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband</title>
<idno type="ISSN">0178-4609</idno>
<imprint><date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Contrast Media (administration & dosage)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Iodobenzoates</term>
<term>Lymphedema (diagnostic imaging)</term>
<term>Lymphography</term>
<term>Triiodobenzoic Acids (administration & dosage)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides triiodo-benzoïques (administration et posologie)</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Iodo-benzoates</term>
<term>Lymphoedème (imagerie diagnostique)</term>
<term>Lymphographie</term>
<term>Méthode en double aveugle</term>
<term>Produits de contraste (administration et posologie)</term>
<term>Relation dose-effet des médicaments</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Contrast Media</term>
<term>Triiodobenzoic Acids</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acides triiodo-benzoïques</term>
<term>Produits de contraste</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Dose-Response Relationship, Drug</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Iodobenzoates</term>
<term>Lymphography</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Iodo-benzoates</term>
<term>Lymphographie</term>
<term>Méthode en double aveugle</term>
<term>Relation dose-effet des médicaments</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name>
<name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name>
<name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name>
<name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00DE44 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00DE44 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:2568790
   |texte=   Indirect lymphography with iotrolan.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:2568790" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Indirect lymphography with iotrolan.

Indirect lymphography with iotrolan.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.